To see the effect of some herbal drug and Basti(medicated kwath of some herbal as well as some non herbal drugs which is given through anal route) in the management of Sthaulya (Obesity).

â??Clinical Evaluation of Efficacy of â??Vrikshamlaâ??and â??Lekhana Bastiâ?? in the management of Sthaulya with special reference to Obesity.â??

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/011954

Enrollment

Registered

2018-02-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- sthaulya (obesity)

Interventions

Intervention1: Capsule Vrikshamla: Capsule Vrikshamla 3 cap (each Cap. 500 mg.) twice a day before meal with lukewarm water for 30 days. Control Intervention1: Lekhana Vasti: Lekhana Vasti in dose of

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient willing to sign the consent form. 2. The patients between the age group of 18 to 60 years in either sex presenting with clinical features of Sthaulya and Obesity. 3. Patient with BMI 30 or more than 30. 4. Waist circumference >=102 cm (40 in) in men or >=88 cm (35 in) in women.

Exclusion criteria

Exclusion criteria: 1. Patient not willing to sign consent form. 2. Patients with complicated and chronic disorder like Nephrotic syndrome, Hypothyroidism, Jaundice, Hepatitis, chronic infections and other serious diseases. 3. Age less than 18 years and more than 60 years. 4. Patient having BMI below 30. 5. Patients having Obesity due to secondary reason such as drug induced or hormonal imbalance. 6. Pregnant women and lactating mother. 7. Patients contraindicated for Vasti as mention in samhitas.

Design outcomes

Primary

Measure	Time frame
patients of both sexes between age group 18-60 years diagnosed as sthaulya (obese) having BMI 30 or more than 30 and Waist circumference â?¥102 cm (40 in) in male or â?¥88 cm (35 in) in female will be selected for relieving sign and symptoms.Timepoint: Patients of both sexes between age group 18-60 years diagnosed as sthaulya (obese) having BMI 30 or more than 30 and Waist circumference â?¥102 cm (40 in) in male or â?¥88 cm (35 in) in female will be selected for relieving sign and symptoms within 1 month.	—

Measure

Time frame

patients of both sexes between age group 18-60 years diagnosed as sthaulya (obese) having BMI 30 or more than 30 and Waist circumference â?¥102 cm (40 in) in male or â?¥88 cm (35 in) in female will be selected for relieving sign and symptoms.Timepoint: Patients of both sexes between age group 18-60 years diagnosed as sthaulya (obese) having BMI 30 or more than 30 and Waist circumference â?¥102 cm (40 in) in male or â?¥88 cm (35 in) in female will be selected for relieving sign and symptoms within 1 month.

—

Secondary

Measure	Time frame
assess comparative efficacy of cap.Vrikshamla (1 month) and Lekhan Basti(15 Basti) in dignosed patients of sthaulya(Obesity).Timepoint: assess comparative efficacy of cap.Vrikshamla (1 month) and Lekhan Basti(15 Basti) in dignosed patients of sthaulya(Obesity) within 1 month.	—

Countries

India

Contacts

Public ContactDr Vivek Kumar Dwivedi

National Institute of Ayurveda

joshirk1964@gmail.com9414322297

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026